 |
인쇄하기
취소
|
Pfizer Korea wins lawsuit over Lyrica patent dispute
Pfizer Korea scored another victory in its Lyrica (Pregabalin) patent dispute against Korean generic drug manufacturers, following the court ruling against CJ Cheil Jedang in May.
The Patent Court of Korea ruled that generic firms had infringed on Pfizer’s patent of Lyrica, which is used to treat chronic pain disorders like fibromyalgia and other neuropathic pain disorders, the Korean unit o...
The Patent Court of Korea ruled that generic firms had infringed on Pfizer’s patent of Lyrica, which is used to treat chronic pain disorders like fibromyalgia and other neuropathic pain disorders, the Korean unit o...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.